Article
A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.
The Tohoku journal of experimental medicine - 1 Feb 1996
Saijyo S, Kudo T, Katayose Y, Saeki H, Chiba N, Suzuki M, Tominaga T, Matsuno S
Abstract excerpt
For the purpose of establishing a new in vitro model of adoptive immunotherapy, we synthesized two kinds of bispecific antibodies (BsAbs), i.e., (OK x L) BsAbs constructed with both OKT-3 (anti-CD3) and L-7-6 (anti-HCC), and (3G x L) BsAbs constructed with 3-G-8 (anti-CD16) and L-7-6 antibodies....
Topics
- Antibodies, Bispecific
- Antibodies, Monoclonal
- Antibody Specificity
- Antineoplastic Agents
- Carcinoma, Hepatocellular
- Cell Division
- Cell Survival
- Humans
- Immunotoxins
- Phenotype
- T-Lymphocytes, Regulatory
- Tetrazolium Salts
- Thiazoles
- Tumor Cells, Cultured